KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) EBT: 2017-2024

Historic EBT for BioNTech SE (BNTX) over the last 8 years, with Dec 2024 value amounting to -$724.2 million.

  • BioNTech SE's EBT fell 83.43% to $28.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$573.6 million, marking a year-over-year decrease of 68.53%. This contributed to the annual value of -$724.2 million for FY2024, which is 156.75% down from last year.
  • BioNTech SE's EBT amounted to -$724.2 million in FY2024, which was down 156.75% from $1.3 billion recorded in FY2023.
  • BioNTech SE's EBT's 5-year high stood at $17.2 billion during FY2021, with a 5-year trough of -$724.2 million in FY2024.
  • Its 3-year average for EBT is $4.6 billion, with a median of $1.3 billion in 2023.
  • In the last 5 years, BioNTech SE's EBT soared by 10,001.67% in 2021 and then slumped by 156.75% in 2024.
  • BioNTech SE's EBT (Yearly) stood at -$173.8 million in 2020, then surged by 10,001.67% to $17.2 billion in 2021, then dropped by 23.22% to $13.2 billion in 2022, then crashed by 90.34% to $1.3 billion in 2023, then crashed by 156.75% to -$724.2 million in 2024.